Microba Life Sciences Limited (MAP) Income Statement
1 Followers
Microba Life Sciences Limited Income Statement
Last quarter (Q4 2022), Microba Life Sciences Limited's total revenue was $―. In Q4, Microba Life Sciences Limited's net income was $―. See Microba Life Sciences Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22
Total Revenue
$ 4.69M
Cost of Revenue
$ 2.32M
Gross Profit
$ 2.37M
Operating Expense
$ 18.64M
Operating Income
$ -16.27M
Net Non Operating Interest Income Expense
$ -5.74K
Other Income Expense
$ 4.82M
Pretax Income
$ -11.46M
Tax Provision
$ 9.23K
Earnings From Equity Interest Net Of Tax
$ ―
Net Income Common Stockholders
$ -11.47M
Basic EPS
$ -0.05
Diluted EPS
$ -0.05
Basic Average Shares
$ 223.08M
Diluted Average Shares
$ 223.08M
Dividend Per Share
$ ―
Total Operating Income As Reported
$ ―
Reported Normalized Basic E P S
$ ―
Reported Normalized Diluted E P S
$ ―
Rent Expense Supplemental
$ ―
Total Expenses
$ ―
Net Income From Continuing And Discontinued Operation
$ -11.47M
Normalized Income
$ -11.47M
Interest Expense
$ 8.31K
EBIT
$ -11.45M
EBITDA
$ -9.91M
Currency in USD
Microba Life Sciences Limited Earnings and Revenue History